Sunday, May 31, 2015 3:00:25 PM
My initial assessment strategically was closest to what transpired recently with the terms of the JNJ/ACHN collaboration than what many had opined since the start of 2015.
Clearly the fly in the ointment was JNJ's Sept 2014 $1.7 bln acquisition of privately held Alios Therapeutics.
Adding more salt to the JNJ/ACHN wound is the below excerpt's from today's Seeking Alpha http://seekingalpha.com/article/3203006-gilead-merck-and-achillion-j-and-j-square-off-in-an-hcv-nuclear-showdown
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM